Corcept Therapeutics
CORT
#1631
Rank
A$18.74 B
Marketcap
A$173.44
Share price
2.24%
Change (1 day)
51.82%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of June 2026 : A$0.44 Billion

According to Corcept Therapeutics 's latest financial reports the company has A$0.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$0.55 B-9.85%
2024-12-31A$0.61 B14.03%
2023-12-31A$0.54 B-14.8%
2022-12-31A$0.63 B105.73%
2021-12-31A$0.30 B-46.2%
2020-12-31A$0.57 B45.41%
2019-12-31A$0.39 B34.3%
2018-12-31A$0.29 B158.19%
2017-12-31A$0.11 B58.99%
2016-12-31A$71.49 M28.81%
2015-12-31A$55.5 M87.34%
2014-12-31A$29.62 M-51.84%
2013-12-31A$61.52 M-31.28%
2012-12-31A$89.52 M131.59%
2011-12-31A$38.65 M59.76%
2010-12-31A$24.19 M-8.93%
2009-12-31A$26.56 M2.38%
2008-12-31A$25.95 M30.65%
2007-12-31A$19.86 M65.59%
2006-12-31A$11.99 M-69.82%
2005-12-31A$39.74 M-17.77%
2004-12-31A$48.33 M210.3%
2003-12-31A$15.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$29.70 B 6,635.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$11.00 B 2,395.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$16.74 B 3,695.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$12.80 B 2,803.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.21 B 2,217.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$15.83 B 3,490.89%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$0.15 B-63.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.22 B-49.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.25 B 183.59%๐Ÿ‡บ๐Ÿ‡ธ USA